Received Nov 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | F4AC3 | IM / LA |
Patient received a second Arexvy (RSV) injection in November of 2025 even though patient had previously received Arexvy (RSV) injection in August 2023. Patient states that she is feeling symptoms of fatigue but also states that she had received an Immunoglobulin injection two days prior. Patient was informed of this event less than 24 hours after receiving the second dose of Arexvy and spoke with the Pharmacist to address any questions and concerns that the patient had. Patient stated that she didn't have any follow up questions and appreciated the Pharmacist taking the time to discuss this with her.
N/A
High blood pressure, High cholesterol, Common Variable Immune Deficiency Syndrome, Restless Leg Syndrome, Non-Specific Angina, Hypothyroidism, and Osteoarthritis.
Repatha, Cyclobenzaprine, Levothyroxine, Gabapentin, Lisinopril, Ropinirole, Metoprolol, Ranexa, and Naprosyn.
Nitroglycerin
N/A